Abstract: The present invention provides methods of treating a retinal disorder comprising administering an effective amount of a neurotrophic factor to a subject having the retinal disorder. The neurotrophic factors useful in the invention include mesencephalic astrocyte-derived neurotrophic factor (manf) and conserved dopamine neurotrophic factor (cdnf). the present invention further comprises pharmaceutical compositions and kits containing manf and cdnf. Patent Methods: Treatment Methods for Retinal Diseases. The present invention provides methods of treating a retinal disorder comprising administering an effective amount of neurotrophic factor to an individual having retinal disorder. Neurotrophic factors useful in the invention include mesenchymal astrocyte-derived neurotrophic factor (manf) and conserved dopamine neurotrophic factor (cdnf). The present invention further comprises pharmaceutical compositions and kits containing manf and cdnf.abstract: the present invention provides methods of treating a retinal disorder comprising administering an effective amount of a neurotrophic factor to a subject having the retinal disorder. the neurotrophic factors useful in the invention include mesencephalic astrocyte-derived neurotrophic factor (manf) and conserved dopamine neurotrophic factor (cdnf). the present invention further comprises pharmaceutical compositions and kits containing manf and cdnf. tradução: resumo patente de invenção: "métodos de tratamento para doenças retinais". a presente invenção provê métodos de tratamento de um distúrbio retinal compreendendo administrar uma quantidade eficaz de fator neurotrófico a um indivíduo tendo o distúrbio retinal. os fatores neurotróficos úteis na invenção incluem fator neurotrófico derivado de astrócito mesenfálico (manf) e fator neurotrófico de dopamina conservada (cdnf). a presente invenção compreende ainda composições farmacêuticas e estojos contendo manf e cdnf.
